EUVIMEDEUVIMED felfedezése
Crossref

Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer

Shen Cao, Yi Tai, Yuhan Wang, Jing Han, Ming Yue Li, Young Joon Surh, Yue Xing iD, Hong Xiang Zuo, Xuejun Jin iD, Juan Ma iD

Phytotherapy Research · 2026-07 · 40 (7) · 4454-4470

DOI: 10.1002/ptr.70329 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-05-08. Written by Shen Cao and 9 co-authors. Institution: Key Laboratory of Natural Medicines of the Changbai Mountain (Yanbian University), Ministry of Education; School of Pharmacy, Yanbian University, Yan…. Major MEDLINE topics: Triterpenes, NLR Family, Pyrin Domain-Containing 3 Protein, Colorectal Neoplasms. Cited 1 times so far (Crossref); 53 references. Funded by: National Natural Science Foundation of China, The Jilin Province Science and Technology Development Plan Project, Crosswise Tasks.

AbsztraktSubjectsBibliográfiai adatokCiteRelated studies

Abstract (original language)

Cucurbitacin B is a naturally occurring tetracyclic triterpenoid extracted from plants in the Cucumis melo L. It demonstrates various pharmacological activities, such as hepatoprotective, anti‐inflammatory, and anti‐tumor effects. However, its therapeutic effect on inflammation‐associated colorectal cancer (CRC) and its mechanism of action have not been elucidated. This study is aimed to investigate the effects of cucurbitacin B on inflammation‐associated CRC and the mechanism of action. In vitro, the effect of cucurbitacin B on the inflammatory response and the related ZNF70/NLRP3 pathway was examined using western blotting, CCK‐8, ELISA, and immunofluorescence assays. In the HCT116/THP‐1 supernatant co‐culture system, EdU, colony formation, and wound healing assays were performed to evaluate the effects of cucurbitacin B on the proliferation, migration, and epithelial‐mesenchymal transition (EMT) progression of HCT116 cells in response to inflammation. In vivo, a mouse model of inflammatory CRC was constructed by administering azoxymethane (AOM) and dextran sodium sulfate (DSS). To study the role of ZNF70, an adenoviral vector AAV was used to knock out ZNF70 in mice. High‐performance liquid chromatography (HPLC) was utilized to assess the toxic impact of cucurbitacin B on mice. Our results indicate that cucurbitacin B reduces the expression of NLRP3 inflammasome‐associated proteins by downregulating the production of ZNF70. The co‐culture experiment showed that cucurbitacin B inhibited the proliferation, migration, and EMT of HCT116 cells in the inflammatory microenvironment. In vivo studies demonstrated that the knockdown of ZNF70 restored body weight, improved colon length, reduced tumor burden, and increased survival rate in AOM/DSS model mice. This effect was further enhanced by the addition of cucurbitacin B. The HPLC results showed that cucurbitacin B was non‐toxic to the heart, liver, spleen, lungs, and kidneys of mice. In conclusion, the downregulation of ZNF70 by cucurbitacin B inhibits the activation of NLRP3 inflammasomes and reduces the promoting effect of the inflammatory microenvironment on CRC proliferation, migration, and the EMT process. Our findings may provide new insights for the development of treatments for inflammation‐associated CRC.

Subjects

MeSH terms (MEDLINE)

TriterpenesNLR Family, Pyrin Domain-Containing 3 ProteinColorectal NeoplasmsAnimalsHumansMiceHCT116 CellsCell ProliferationInflammationCell MovementMaleEpithelial-Mesenchymal TransitionMice, Inbred C57BLDextran SulfateAzoxymethane

Author keywords

EMTNLRP3 inflammasomeZNF70colorectal cancercucurbitacin B

Substances

cucurbitacin BTriterpenesNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanDextran SulfateAzoxymethane

Authors and institutions

  • Key Laboratory of Natural Medicines of the Changbai Mountain (Yanbian University), Ministry of Education; School of Pharmacy, Yanbian University, Yanji, Jilin Province, China.
  • Key Laboratory of Drug Targets and Pharmacological Screening in Colleges and Universities of Jilin Province; Yanbian University, Yanji, Jilin Province, China.
  • Molecular Medicines Research Center, School of Pharmacy, Yanbian University, Yanji, Jilin Province, China.
  • College of Pharmacy, Seoul National University, Seoul, South Korea.
  • Cancer Research Institute, Seoul National University, Seoul, South Korea.

ORCID profiles: Yue Xing, Xuejun Jin, Juan Ma

Funding

  • National Natural Science Foundation of China
  • The Jilin Province Science and Technology Development Plan Project
  • Crosswise Tasks

Cite

APA

Cao, S., Tai, Y., Wang, Y., Han, J., Li, M. Y., Surh, Y. J., Xing, Y., Zuo, H. X., Jin, X., & Ma, J. (2026). Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer. Phytotherapy Research, 40(7), 4454-4470. https://doi.org/10.1002/ptr.70329

Vancouver

Cao S, Tai Y, Wang Y, Han J, Li MY, Surh YJ, et al. Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer. Phytotherapy Research. 2026;40(7):4454-4470. doi:10.1002/ptr.70329

BibTeX
@article{Cao2026,
  author = {Cao, Shen and Tai, Yi and Wang, Yuhan and Han, Jing and Li, Ming Yue and Surh, Young Joon and Xing, Yue and Zuo, Hong Xiang and Jin, Xuejun and Ma, Juan},
  title = {Mechanism of Cucurbitacin B Targeting ZNF70 / NLRP3 Axis Against Inflammation‐Associated Colorectal Cancer},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {4454--4470},
  doi = {10.1002/ptr.70329}
}
Start for free →